Suppressors of cytokine signaling 4 and 5 regulate epidermal growth factor receptor signaling

被引:120
作者
Kario, E
Marmor, MD
Adamsky, K
Citri, A
Amit, I
Amariglio, N
Rechavi, G
Yarden, Y [1 ]
机构
[1] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel
[2] Tel Aviv Univ, Chaim Sheba Med Ctr, Dept Pediat Hematooncol & Funct Genom, IL-69978 Tel Aviv, Israel
[3] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
关键词
D O I
10.1074/jbc.M408575200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Suppressors of cytokine signaling (SOCS) are Src homology-2-containing proteins originally identified as negative regulators of cytokine signaling. Accumulating evidence indicates a role for SOCS proteins in the regulation of additional signaling pathways including receptor tyrosine kinases. Notably, SOCS36E, the Drosophila ortholog of mammalian SOCS5, was recently implicated as a negative regulator of the Drosophila ortholog of EGFR. In this study, we aimed at characterizing the role of SOCS5 in the negative regulation of EGFR. Here we show that the expression of SOCS5 and its closest homolog SOCS4 is elevated in cells following treatment with EGF, similar to several negative feedback regulators of EGFR whose expression is up-regulated upon receptor activation. The expression of SOCS5 led to a marked reduction in EGFR expression levels by promoting EGFR degradation. The reduction in EGFR levels and EGF-induced signaling in SOCS5-expressing cells requires both the Src homology-2 and SOCS box domains of SOCS5. Interestingly, EGFR is degraded by SOCS5 prior to EGF treatment in a ligand- and c-Cbl-independent manner. SOCS5 can associate with EGFR and can also bind the ElonginBC protein complex via its SOCS box, which may recruit an E3 ubiquitin ligase to promote EGFR degradation. Thus, we have characterized a novel function for SOCS5 in regulating EGFR and discuss its potential role in controlling EGFR homeostasis.
引用
收藏
页码:7038 / 7048
页数:11
相关论文
共 48 条
[1]   Suppressors of cytokine signalling (SOCS) in the immune system [J].
Alexander, WS .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (06) :410-416
[2]   TUMOR-INDUCTION BY ACTIVATED ABL INVOLVES TYROSINE PHOSPHORYLATION OF THE PRODUCT OF THE CBL ONCOGENE [J].
ANDONIOU, CE ;
THIEN, CBF ;
LANGDON, WY .
EMBO JOURNAL, 1994, 13 (19) :4515-4523
[3]   ELONGIN (SIII) - A MULTISUBUNIT REGULATOR OF ELONGATION BY RNA-POLYMERASE-II [J].
ASO, T ;
LANE, WS ;
CONAWAY, JW ;
CONAWAY, RC .
SCIENCE, 1995, 269 (5229) :1439-1443
[4]   Biochemical and functional interactions between the neurotrophin receptors trk and p75NTR [J].
Bibel, M ;
Hoppe, E ;
Barde, YA .
EMBO JOURNAL, 1999, 18 (03) :616-622
[5]   SOCS5 is expressed in primary B and T lymphoid cells but is dispensable for lymphocyte production and function [J].
Brender, C ;
Columbus, R ;
Metcalf, D ;
Handman, E ;
Starr, R ;
Huntington, N ;
Tarlinton, D ;
Odum, N ;
Nicholson, SE ;
Nicola, NA ;
Hilton, DJ ;
Alexander, WS .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (13) :6094-6103
[6]  
Brock P, 1999, CYTOMETRY, V35, P353, DOI 10.1002/(SICI)1097-0320(19990401)35:4<353::AID-CYTO8>3.0.CO
[7]  
2-M
[8]   Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras [J].
Cacalano, NA ;
Sanden, D ;
Johnston, JA .
NATURE CELL BIOLOGY, 2001, 3 (05) :460-465
[9]   SOCS36E, a novel Drosophila SOCS protein, suppresses JAK/STAT and EGF-R signalling in the imaginal wing disc [J].
Callus, BA ;
Mathey-Prevot, B .
ONCOGENE, 2002, 21 (31) :4812-4821
[10]  
de Melker AA, 2001, J CELL SCI, V114, P2167